These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells. Evangelista S; Garbin U; Pasini AF; Stranieri C; Boccioletti V; Cominacini L Pharmacol Res; 2007 Apr; 55(4):303-9. PubMed ID: 17280840 [TBL] [Abstract][Full Text] [Related]
11. Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats. Wang Y; Zhang F; Liu Y; Yin S; Pang X; Li Z; Wei Z Clin Exp Hypertens; 2017; 39(7):628-639. PubMed ID: 28640644 [TBL] [Abstract][Full Text] [Related]
12. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients. Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860 [TBL] [Abstract][Full Text] [Related]
13. Nebivolol: impact on cardiac and endothelial function and clinical utility. Toblli JE; DiGennaro F; Giani JF; Dominici FP Vasc Health Risk Manag; 2012; 8():151-60. PubMed ID: 22454559 [TBL] [Abstract][Full Text] [Related]
14. Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. Taddei S; Virdis A; Ghiadoni L; Magagna A; Pasini AF; Garbin U; Cominacini L; Salvetti A J Hypertens; 2001 Aug; 19(8):1379-86. PubMed ID: 11518845 [TBL] [Abstract][Full Text] [Related]
15. Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1 -selective receptor blockade. Cosentino F; Bonetti S; Rehorik R; Eto M; Werner-Felmayer G; Volpe M; Lüscher TF J Hypertens; 2002 Mar; 20(3):421-8. PubMed ID: 11875309 [TBL] [Abstract][Full Text] [Related]
16. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats. Wang Y; Zhang M; Liu Y; Liu Y; Chen M Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314 [TBL] [Abstract][Full Text] [Related]
17. Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study. Redón J; Pascual-Izuel JM; Rodilla E; Vicente A; Oliván J; Bonet J; Torguet JP; Calaforra O; Almirall J Blood Press; 2014 Jun; 23(3):181-8. PubMed ID: 24059690 [TBL] [Abstract][Full Text] [Related]
18. [Comparison of effects of nebivolol and atenolol on P-wave dispersion in patients with hypertension]. Tuncer M; Fettser DV; Gunes Y; Batyraliev TA; Guntekin U; Gumrukchuoglu KhA; Eryonucu B; Guler N; Sidorenko BA Kardiologiia; 2008; 48(4):42-5. PubMed ID: 18447840 [TBL] [Abstract][Full Text] [Related]
19. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients. Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354 [TBL] [Abstract][Full Text] [Related]
20. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity. Mason RP; Kubant R; Jacob RF; Walter MF; Boychuk B; Malinski T J Cardiovasc Pharmacol; 2006 Jul; 48(1):862-9. PubMed ID: 16891916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]